Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Netherlands Heart Journal 2/2009

01-02-2009 | Review article

Women’s health in menopause with a focus on hypertension

Auteurs: A. H. E. M. Maas, H. R. Franke

Gepubliceerd in: Netherlands Heart Journal | Uitgave 2/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

In menopause transition many women have vasomotor symptoms which may affect their normal daily activities. With the decline in oestrogen levels, risk factors for coronary heart disease (CHD) become more apparent, especially hypertension. The onset of hypertension can cause a variety of complaints that are often attributed to the menopause. Risk factor identification is poorly managed in middle-aged women and should be the first step in the evaluation and treatment of women with perimenopausal symptoms. In women at low risk for CHD, there is still a window of opportunity for safe hormone prescription in the first years proximal to menopause. (Neth Heart J 2009;17:68-72.)
Literatuur
1.
go back to reference Hulley S, Grady D, Bush T, Furberg C, Herrington DM, Riggs B, et al. The Heart and Estrogen/progestin Replacement Study (HERS) research group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women . JAMA 1998; 280: 605-13. Hulley S, Grady D, Bush T, Furberg C, Herrington DM, Riggs B, et al. The Heart and Estrogen/progestin Replacement Study (HERS) research group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women . JAMA 1998; 280: 605-13.
2.
go back to reference Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000; 343: 522-9. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000; 343: 522-9.
3.
go back to reference Writing group for the Women’s Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results of the Women’s Health Initiative controlled trial. JAMA 2002; 288: 321-33. Writing group for the Women’s Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results of the Women’s Health Initiative controlled trial. JAMA 2002; 288: 321-33.
4.
go back to reference The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women’s Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-12. The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women’s Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-12.
5.
go back to reference Collins P, Rosano G, Casey C, Daly C, Gambacciani M, Hadji P, et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J 2007; 28: 2028-40. Collins P, Rosano G, Casey C, Daly C, Gambacciani M, Hadji P, et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J 2007; 28: 2028-40.
6.
go back to reference Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978; 89: 157-61. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978; 89: 157-61.
7.
go back to reference Bairey Merz CM, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003; 41: 413-9. Bairey Merz CM, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003; 41: 413-9.
8.
go back to reference Sutton-Tyrell K, Lassila HC, Meilahn E, Bunker C, Metthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998; 29: 1116-21. Sutton-Tyrell K, Lassila HC, Meilahn E, Bunker C, Metthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998; 29: 1116-21.
9.
go back to reference Christian RC, Harrington S, Edwards WD, Oberg AL, Fitzpatrick LA. Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women . J Clin Endocrinol Metab 2002; 87: 1062-7. Christian RC, Harrington S, Edwards WD, Oberg AL, Fitzpatrick LA. Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women . J Clin Endocrinol Metab 2002; 87: 1062-7.
10.
go back to reference Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999; 43: 985-91. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999; 43: 985-91.
11.
go back to reference Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression . Menopause 2007; 14: 373-84. Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression . Menopause 2007; 14: 373-84.
12.
go back to reference Ouyang P, Michos ED, Karas RH. Hormone replacement therapy and the cardiovascular system. J Am Coll Cardiol 2006; 47: 1741-53. Ouyang P, Michos ED, Karas RH. Hormone replacement therapy and the cardiovascular system. J Am Coll Cardiol 2006; 47: 1741-53.
13.
go back to reference Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, et al. Main morbidities recorded in the women’s international study of long duration oestrogen after menopause (WISDOM): a randomized controlled trial of hormone replacement therapy in postmenopausal women. BMJ 2007; 335: 239-50. Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, et al. Main morbidities recorded in the women’s international study of long duration oestrogen after menopause (WISDOM): a randomized controlled trial of hormone replacement therapy in postmenopausal women. BMJ 2007; 335: 239-50.
14.
go back to reference Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PWF, Houston-Miller N. Task force #1- Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol 2003; 41: 1863-74. Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PWF, Houston-Miller N. Task force #1- Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol 2003; 41: 1863-74.
15.
go back to reference Mikkola TS, Clarkson TB, Notelovitz M. Postmenopausal hormone therapy before and after the women’s health initiative study: what consequences? Ann Med 2004; 36: 402-13. Mikkola TS, Clarkson TB, Notelovitz M. Postmenopausal hormone therapy before and after the women’s health initiative study: what consequences? Ann Med 2004; 36: 402-13.
16.
go back to reference Rossouw JE, Prentice RL, Manson JE, Wu LL, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465-77. Rossouw JE, Prentice RL, Manson JE, Wu LL, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465-77.
17.
go back to reference Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007; 356: 2591-602. Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007; 356: 2591-602.
18.
go back to reference Vitale C, Mercuro G, Cerquetani E, Marazzi G, Patrizi R, Pellicia F et al. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Throm Vasc Biol 2008; 28: 348-52. Vitale C, Mercuro G, Cerquetani E, Marazzi G, Patrizi R, Pellicia F et al. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Throm Vasc Biol 2008; 28: 348-52.
19.
go back to reference Freedman RR, Norton D, Woodward S, Cornelissen G. Core body temperature and circadian rythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995; 80: 2354-8. Freedman RR, Norton D, Woodward S, Cornelissen G. Core body temperature and circadian rythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995; 80: 2354-8.
20.
go back to reference Nelson HG. Menopause. Lancet 2008; 371: 760-70. Nelson HG. Menopause. Lancet 2008; 371: 760-70.
21.
go back to reference Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal hot flashes. J Womens Health 1998; 7: 1149-55. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal hot flashes. J Womens Health 1998; 7: 1149-55.
22.
go back to reference Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000; 152: 463-73. Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000; 152: 463-73.
23.
go back to reference Thurston RC, Sowers MR, Sutton-Tyrrell K, Everson-Rose SA, Lewis TT, Edmundowicz D, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008; 15: 429-34. Thurston RC, Sowers MR, Sutton-Tyrrell K, Everson-Rose SA, Lewis TT, Edmundowicz D, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008; 15: 429-34.
24.
go back to reference Gerber LM, Sievert LL, Warren K, Pickering TG, Schwartz JE. Hot flashes are associated with increased ambulatory blood pressure. Menopause 2007; 14: 308-15. Gerber LM, Sievert LL, Warren K, Pickering TG, Schwartz JE. Hot flashes are associated with increased ambulatory blood pressure. Menopause 2007; 14: 308-15.
25.
go back to reference James GD, Sievert LL, Flanagan E. Ambulatory blood pressure and heart rate in relation to hot flash experience among women of menopausal age. Ann Human Biol 2004; 31: 49-58. James GD, Sievert LL, Flanagan E. Ambulatory blood pressure and heart rate in relation to hot flash experience among women of menopausal age. Ann Human Biol 2004; 31: 49-58.
26.
go back to reference Ikeda H, Inoue T, Uemura S, Kaibara R, Tanaka H, Node K. Effects of candesartan for middle-aged and elderly women with hypertension and menopausal-like symptoms. Hypertens Res 2006; 29: 1007-12. Ikeda H, Inoue T, Uemura S, Kaibara R, Tanaka H, Node K. Effects of candesartan for middle-aged and elderly women with hypertension and menopausal-like symptoms. Hypertens Res 2006; 29: 1007-12.
27.
go back to reference Freedman RR. Biochemical, metabolic and vascular mechanisms in menopausal hot flashes. Fertil Steril 1998; 70: 332-7. Freedman RR. Biochemical, metabolic and vascular mechanisms in menopausal hot flashes. Fertil Steril 1998; 70: 332-7.
28.
go back to reference Wenger NK. Coronary heart disease: an older women’s major health risk. BMJ 1997; 5: 1085-90. Wenger NK. Coronary heart disease: an older women’s major health risk. BMJ 1997; 5: 1085-90.
29.
go back to reference Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-13. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-13.
30.
go back to reference Wassertheil-Smoller S, Anderson G, Psaty BM, Black HR, Manson JE, Wong N, et al. Hypertension and its treatment in postmenopausal women. Baseline data from the Women’s Health Initiative. Hypertension 2000; 36: 780-9. Wassertheil-Smoller S, Anderson G, Psaty BM, Black HR, Manson JE, Wong N, et al. Hypertension and its treatment in postmenopausal women. Baseline data from the Women’s Health Initiative. Hypertension 2000; 36: 780-9.
31.
go back to reference Fletcher AE, Bulpitt CJ, Tuomilehto J et al., on behalf of the Syst-Eur Trial investigators. Quality of life in elderly patients with isolated systolic hypertension: baseline data from the Syst-Eur Trial. J Hypertens 1998; 16: 1117-24. Fletcher AE, Bulpitt CJ, Tuomilehto J et al., on behalf of the Syst-Eur Trial investigators. Quality of life in elderly patients with isolated systolic hypertension: baseline data from the Syst-Eur Trial. J Hypertens 1998; 16: 1117-24.
32.
go back to reference Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335: 974-85. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335: 974-85.
33.
go back to reference Conen D, Ridker PM, Buring JE, Glynn RJ. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ 2007; 335: 432-40. Conen D, Ridker PM, Buring JE, Glynn RJ. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ 2007; 335: 432-40.
34.
go back to reference Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: The Women’s Health Study. Eur Heart J 2007; 28: 2937-43. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: The Women’s Health Study. Eur Heart J 2007; 28: 2937-43.
35.
go back to reference Gierach GL, Johnson BD, Bairey Merz CN, Kelsey SF, Bittner V, Olson MB, et al. Hypertension, Menopause, and coronary artery disease risk in the Women’s Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006; 47: 50S-58S. Gierach GL, Johnson BD, Bairey Merz CN, Kelsey SF, Bittner V, Olson MB, et al. Hypertension, Menopause, and coronary artery disease risk in the Women’s Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006; 47: 50S-58S.
36.
go back to reference Oparil S. Women and hypertension. What did we learn from the Women’s Health Initiative? Cardiol Rev 2006; 14: 267-75. Oparil S. Women and hypertension. What did we learn from the Women’s Health Initiative? Cardiol Rev 2006; 14: 267-75.
37.
go back to reference Staessen JA, van der Heijden-Spek JJ, Safar ME, Den Hond E, Gasowski J, Fagard RH, et al. Menopause and the characteristics of the large arteries in a population study. J Hum Hypertens 2001; 15: 511-8. Staessen JA, van der Heijden-Spek JJ, Safar ME, Den Hond E, Gasowski J, Fagard RH, et al. Menopause and the characteristics of the large arteries in a population study. J Hum Hypertens 2001; 15: 511-8.
38.
go back to reference Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension. An age-old debate. Hypertension 2008; 51: 952-9. Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension. An age-old debate. Hypertension 2008; 51: 952-9.
39.
go back to reference Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension 2005; 46: 249-54. Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension 2005; 46: 249-54.
40.
go back to reference Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension 2001; 37: 1199-208. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension 2001; 37: 1199-208.
41.
go back to reference Ashraf MS, Vongpatanasin W. Estrogen and hypertension. Curr Hypertens Reports 2006; 8: 368-76. Ashraf MS, Vongpatanasin W. Estrogen and hypertension. Curr Hypertens Reports 2006; 8: 368-76.
42.
go back to reference Reckelhoff JF, Fortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension 2004; 43: 918-23. Reckelhoff JF, Fortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension 2004; 43: 918-23.
43.
go back to reference Schunkert H, Danser AH, Hense H-W, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the reninangiotensin system in postmenopausal women. Circulation 1997; 95: 39-45. Schunkert H, Danser AH, Hense H-W, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the reninangiotensin system in postmenopausal women. Circulation 1997; 95: 39-45.
44.
go back to reference Pechère-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 2004; 17: 994-1001. Pechère-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 2004; 17: 994-1001.
45.
go back to reference Narkiewicz K, Philips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective interaction between aging, blood pressure and sympathetic nerve activity. Hypertension 2005; 45: 522-5. Narkiewicz K, Philips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective interaction between aging, blood pressure and sympathetic nerve activity. Hypertension 2005; 45: 522-5.
46.
go back to reference Rappelli A. Hypertension and obesity after the menopause. J Hypertens 2002; 20: S26-S28. Rappelli A. Hypertension and obesity after the menopause. J Hypertens 2002; 20: S26-S28.
47.
go back to reference Carr MC. The emerge of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88: 2404-11. Carr MC. The emerge of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88: 2404-11.
48.
go back to reference Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PWF, et al.Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006; 113: 791-8. Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PWF, et al.Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006; 113: 791-8.
49.
go back to reference Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, et al. Evidence- based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol 2007; 49: 1230-50. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, et al. Evidence- based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol 2007; 49: 1230-50.
50.
go back to reference Guidelines Committee. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007; 28: 2375-414. www.escardio.org/admin/GuidelinesReferences/guidelines-CVD-prevention-ES.pdf Guidelines Committee. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007; 28: 2375-414. www.escardio.org/admin/GuidelinesReferences/guidelines-CVD-prevention-ES.pdf
51.
go back to reference Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE-project. Eur Heart J 2003; 24: 987-1003. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE-project. Eur Heart J 2003; 24: 987-1003.
52.
go back to reference Grady D. Management of menopausal symptoms. N Engl J Med 2006; 355: 2338-47. Grady D. Management of menopausal symptoms. N Engl J Med 2006; 355: 2338-47.
53.
go back to reference Board of trustees of the North American Menopause Society (NAMS). Estrogen and progestogen use in postmenopausal women: July 2008 position statement of the North American Menopause Society. Menopause 2008; 15: 584-603. Board of trustees of the North American Menopause Society (NAMS). Estrogen and progestogen use in postmenopausal women: July 2008 position statement of the North American Menopause Society. Menopause 2008; 15: 584-603.
54.
go back to reference Roberts H. Managing the Menopause. BMJ 2007; 334: 736-41. Roberts H. Managing the Menopause. BMJ 2007; 334: 736-41.
55.
go back to reference White WB, Hanes V, Chauhan V, Pitt B. Effects of a new hormone therapy, drospirenone and 17ß-oestradiol in postmenopausal women with hypertension. Hypertension 2006; 48: 246-53. White WB, Hanes V, Chauhan V, Pitt B. Effects of a new hormone therapy, drospirenone and 17ß-oestradiol in postmenopausal women with hypertension. Hypertension 2006; 48: 246-53.
56.
go back to reference Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Larara AH. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. Menopause 2007; 14: 408-14. Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Larara AH. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. Menopause 2007; 14: 408-14.
Metagegevens
Titel
Women’s health in menopause with a focus on hypertension
Auteurs
A. H. E. M. Maas
H. R. Franke
Publicatiedatum
01-02-2009
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 2/2009
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03086220

Andere artikelen Uitgave 2/2009

Netherlands Heart Journal 2/2009 Naar de uitgave

Interuniversity Cardiology Institute of the Netherlands

Ultrasound and microbubble-targeted delivery of therapeutic compounds